Decitabine is a hypomethylating agent used primarily in the treatment of certain types of cancers, particularly acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS). It works by incorporating into DNA and inhibiting DNA methyltransferase, leading to hypomethylation of DNA and reactivation of silenced genes that can suppress tumor growth.
